NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

If anyone thinks that Linda Powers will be able to pull off a tissue-agnostic approval without the influence and alignment of BP players, then I’ve got a bridge in Brooklyn I’d like to sell them.

There is no doubt that NWBO will need to closely align with Merck and other BP players in order to quickly and efficiently advance DCVax. I severely question that a simple license agreement(s) will offer anywhere near the same strategic alignment and benefit that an actual equity partner(s) will bring to the table.

Just think of it this way. At least hypothetically, the same time NWBO has simple license agreement(s) with one or multiple BP to sell DCVax, they’re would also be pursuing a designation that will compete with the licensees’ other cancer treatments. That just looks like a recipe for trouble making at all levels.

I agree with BB that a syndication or JV makes the most sense under the circumstances. If licensing is the best option they can pursue, then that’s not by choice, regardless of what her posse is whipping up.